Get started
Author

María José Catalán

Observed names: Catalán, María José, M. Catalan, M. J. Catalán, M.J. Catalan, M.J. Catalán, Maria Catalán, Maria J. Catalán, Maria Jose Catalan, Maria Jose Catalán, Maria José Catalán, María J Catalán, María J. Catalán, María-José Catalán, María‐José Catalán
Observed institutions: Universidad Complutense de Madrid, National Institutes of Health, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Hospital Universitario 12 De Octubre, National Institute of Neurological Disorders and Stroke, International Parkinson and Movement Disorder Society
ORCID: 0000-0001-8748-7891
Observed ORCID: 0000-0001-8748-7891
OpenAlex ID: A5110166186
The functional neuroanatomy of simple and complex sequential finger movements: a PET study
1998 · M. Catalan · Brain · 408
Abnormal somatosensory homunculus in dystonia of the hand
1998 · William Bara‐Jimenez, Maria Jose Catalan, et al. · Annals of Neurology · 404
Caregiver burden in Parkinson's disease
2007 · Pablo Martínez‐Martín, Maria João Forjaz, et al. · Movement Disorders · 299
A PET study of sequential finger movements of varying length in patients with Parkinson's disease
1999 · Maria Jose Catalan, Kenji Ishii, et al. · Brain · 218
Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort
2019 · D. Santos García, T. de Deus Fonticoba, et al. · Parkinsonism & Related Disorders · 150
In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease
2014 · Álvaro Sánchez‐Ferro, Alberto Rábano, et al. · Movement Disorders · 132
Impact of Fatigue in Parkinson’s Disease: The Fatigue Impact Scale for Daily Use (D-FIS)
2006 · Pablo Martinez-Martin, Maria Jose Catalan, et al. · Quality of Life Research · 91
Minimal Clinically Important Difference for UPDRS‐III in Daily Practice
2018 · Álvaro Sánchez‐Ferro, Michele Matarazzo, et al. · Movement Disorders Clinical Practice · 67
PDF
Health‐related quality of life evaluation by proxy in Parkinson's disease: Approach using PDQ‐8 and EuroQoL‐5D
2003 · Pablo Martínez‐Martín, Julián Benito‐León, et al. · Movement Disorders · 65
Levodopa infusion improves impulsivity and dopamine dysregulation syndrome in Parkinson's disease
2013 · María José Catalán, Eduardo de Pablo‐Fernández, et al. · Movement Disorders · 61
Non‐motor symptom burden is strongly correlated to motor complications in patients with Parkinson’s disease
2020 · D. Santos‐García, T. de Deus Fonticoba, et al. · European Journal of Neurology · 60
Neurostimulation for Advanced Parkinson Disease and Quality of Life at 5 Years: A Nonrandomized Controlled Trial
2024 · Stefanie T. Jost, Salima Aloui, et al. · JAMA Network Open · 54
PDF
Predictors of clinically significant quality of life impairment in Parkinson’s disease
2021 · Diego Santos García, Teresa de Deus Fonticoba, et al. · npj Parkinson s Disease · 50
PDF
COPPADIS ‐2015 ( CO hort of Patients with PArkinson's DI sease in Spain, 2015): an ongoing global Parkinson's disease project about disease progression with more than 1000 subjects included. Results from the baseline evaluation
2019 · D. Santos García, S. Jesús, et al. · European Journal of Neurology · 46
Remote Monitoring of Treatment Response in Parkinson's Disease: The Habit of Typing on a Computer
2019 · Michele Matarazzo, Teresa Arroyo‐Gallego, et al. · Movement Disorders · 44
Improvement of impulse control disorders associated with levodopa–carbidopa intestinal gel treatment in advanced Parkinson’s disease
2018 · On behalf of the EDIS Study Group, Maria Jose Catalan, et al. · Journal of Neurology · 39
Long-term directional deep brain stimulation: Monopolar review vs. local field potential guided programming
2022 · Carla Fernández-García, Mariana H.G. Monje, et al. · Brain stimulation · 35
PDF
Serum levels of β-carotene and other carotenoids in Parkinson's disease
1993 · Félix Javier Jiménez-Jiménez, JoséAntonio Molina, et al. · Neuroscience Letters · 34
Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
2021 · Saul Martínez-Horta, Helena Bejr-Kasem, et al. · BMC Neurology · 28
PDF
Validation of a Spanish Version of the Lille Apathy Rating Scale for Parkinson’s Disease
2014 · Rocio García-Ramos, Clara Villanueva Iza, et al. · The Scientific World JOURNAL · 27
PDF
Home-based transcranial static magnetic field stimulation of the motor cortex for treating levodopa-induced dyskinesias in Parkinson's disease: A randomized controlled trial
2022 · Michele Dileone, Claudia Ammann, et al. · Brain stimulation · 26
PDF
Long-term Effectiveness of levodopa–carbidopa Intestinal Gel in 177 Spanish Patients With Advanced Parkinson’s Disease
2016 · Francesc Valldeoriola, Francisco Grandas, et al. · Neurodegenerative Disease Management · 26
Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
2021 · Francesc Valldeoriola, María José Catalán, et al. · npj Parkinson s Disease · 25
PDF
Sleep Problems Are Related to a Worse Quality of Life and a Greater Non-Motor Symptoms Burden in Parkinson’s Disease
2020 · Diego Santos-García, E. Suárez Castro, et al. · Journal of Geriatric Psychiatry and Neurology · 25
PDF
Quality of life and non-motor symptoms in Parkinson's disease patients with subthreshold depression
2020 · D. Santos-García, T. de Deus Fonticoba, et al. · Journal of the Neurological Sciences · 20
Works count: 48
Citation count: 2,566
H-index: 24
I10-index: 31
Year
Topic
Type